24 Nov 2006

Pharmaceutical company Meda held the bank meeting for the amendment to its Eu575m five year loan in Stockholm this week. The amendment is to several financial covenants on the loan and will allow the borrower to take on more debt for its purchase of the European drug wing ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial